Skip to main content
Clinical Trials/JPRN-UMIN000016070
JPRN-UMIN000016070Completed未知

Comparison of efficacy for suppression of hepatocellular carcinoma after antiviral treatment between interferon beta and ribavirin treatment and pegylated interferon alpha and ribavirin treatment - Efficacy of interferon beta and ribavirin treatment for suppression of hepatocellular carcinoma

Department of General Internal Medicine, Kyushu University Hospital0 sites800 target enrollmentStarted: January 1, 2015Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
800

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional,observational

Eligibility Criteria

Ages
18years-old to 80years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Exclusion criteria for this study were: 1. presence of hepatocellular carcinoma, 2. shortening of treatment, 3. extension of treatment, 4. positivity of HIV or hepatitis B virus surface antigen, 5. severe depression, 6. hepatic decompensation, 7. excessive active alcohol consumption or drug abuse, 8. treatment with antiviral or immnosuppressive agents

Investigators

Sponsor
Department of General Internal Medicine, Kyushu University Hospital

Similar Trials

Comparison of efficacy for suppression of... | Clinical Trial